Breaking News Instant updates and real-time market news.

2020-06-09 07:08:41 XENT Intersect ENT $12.71 / +0.03 (+0.24%) 07:08 06/09/20 06/09 07:08 06/09/20 07:08	Intersect ENT announces CMS approval of SINUVA for reimbursement Intersect ENT announced that the Centers for Medicare and Medicaid Services, or CMS, has approved SINUVA Sinus Implant for transitional pass-through payment status for reimbursement under the Hospital Outpatient Prospective Payment System, or OPPS, and Ambulatory Surgery Center Payment System. The new code, C9122 Mometasone furoate sinus implant, 10 micrograms, is scheduled to take effect July 1. Pass-Through status lasts for three years.
XENT Intersect ENT $12.71 / +0.03 (+0.24%) 05/12/20 Canaccord Intersect ENT downgraded to Hold from Buy at Canaccord 05/12/20 Piper Sandler Intersect ENT price target lowered to $14 from $23 at Piper Sandler 04/15/20 BofA Intersect ENT double-downgraded to Underperform from Buy at BofA 04/15/20 BofA Intersect ENT downgraded to Underperform from Buy at BofA

2020-06-09 07:08:41

XENT

Intersect ENT

$12.71 / +0.03 (+0.24%)

07:08

06/09/20

06/09

07:08

06/09/20

07:08

Intersect ENT announces CMS approval of SINUVA for reimbursement

Intersect ENT announced that the Centers for Medicare and Medicaid Services, or CMS, has approved SINUVA Sinus Implant for transitional pass-through payment status for reimbursement under the Hospital Outpatient Prospective Payment System, or OPPS, and Ambulatory Surgery Center Payment System. The new code, C9122 Mometasone furoate sinus implant, 10 micrograms, is scheduled to take effect July 1. Pass-Through status lasts for three years.

XENT Intersect ENT

$12.71 / +0.03 (+0.24%)

05/12/20 Canaccord: Intersect ENT downgraded to Hold from Buy at Canaccord

05/12/20 Piper Sandler: Intersect ENT price target lowered to $14 from $23 at Piper Sandler

04/15/20 BofA: Intersect ENT double-downgraded to Underperform from Buy at BofA

04/15/20 BofA: Intersect ENT downgraded to Underperform from Buy at BofA

TODAY'S FREE FLY STORIES

Hot Stocks	Durect discontinues Covid trial due to lack of patients, other treatments » 16:10 03/04/21 03/04 16:10 03/04/21 16:10 DRRX Durect $2.04 / -0.145 (-6.65%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events DRRX Durect $2.04 / -0.145 (-6.65%) 02/02/21 Durect announces FDA approval of POSIMIR 02/02/21 Durect jumps over 40% after FDA posts approval of pain drug 02/02/21 FDA posts approval of Durect pain treatment Posimir 01/25/21 Durect doses first patient in AHFIRM Phase 2b study of DUR-928 DRRX Durect $2.04 / -0.145 (-6.65%) 02/03/21 Jefferies Posimir should not be significant threat to Pacira's Exparel, says Jefferies 02/03/21 Chardan Chardan boosts Durect target to $8 with 'final overhang' removed 02/02/21 Oppenheimer Posimir approval a 'significant positive' for Durect, says Oppenheimer 02/02/21 Roth Capital Roth reiterates $7 target on Durect after 'surprise' FDA approval DRRX Durect $2.04 / -0.145 (-6.65%) 11/02/20 Durect reports Q3 EPS (5c), consensus (4c) 04 Feb DRRX Durect $2.04 / -0.145 (-6.65%) 11/03/20 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference 16:30 Today Durect - DRRX
Earnings	Identiv reports Q4 EPS (5c), consensus (5c) » 16:10 03/04/21 03/04 16:10 03/04/21 16:10 INVE Identiv $10.89 / -0.37 (-3.29%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events INVE Identiv $10.89 / -0.37 (-3.29%) 02/11/21 Identiv amended its short term debt facility with EWB 02/09/21 Identiv announces 2021 strategic priorities 02/09/21 Identiv 'well-positioned' to meet 20%-25% revenue growth guidance in 1H21 12/30/20 Identiv announces early repayment of East West Bank term loan INVE Identiv $10.89 / -0.37 (-3.29%) 09/28/20 Northland Identiv benefitting as Apple supports NFC, says Northland 09/22/20 Lake Street Identiv price target raised to $8 after management meeting at Lake Street INVE Identiv $10.89 / -0.37 (-3.29%) 02/09/21 Identiv sees Q4 revenue $24.6M-$24.8M, consensus $24.94M 11/10/20 Identiv reports Q3 EPS 1c, consensus 0c 10/29/20 Identiv sees Q3 EPS 0c-1c, consensus (2c) 03/15/21 33rd Annual Roth Virtual Conference 17:00 Today Identiv - INVE
Earnings	Medallia sees FY22 revenue $563M-$567M, consensus $554.79M » 16:09 03/04/21 03/04 16:09 03/04/21 16:09 MDLA Medallia $37.59 / -2.24 (-5.62%) Sees FY22 subscription… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MDLA Medallia $37.59 / -2.24 (-5.62%) 03/01/21 Medallia announces partnership with USA Rugby 01/21/21 U.S. HHS selects Medallia to improve key services 01/19/21 Medallia Speech gets FedRAM authorization, HIPAA compliance 01/07/21 Medallia's video feedback solution LivingLens achieves HIPAA compliance MDLA Medallia $37.59 / -2.24 (-5.62%) 06:38 Today Citi Citi adds Medallia to 'Value Creators' list, removes Dropbox 02/23/21 Citi Medallia upgraded to Buy from Neutral at Citi 01/19/21 BTIG Medallia price target raised to $49 from $37 at BTIG 01/19/21 BofA Medallia initiated with a Buy at BofA MDLA Medallia $37.59 / -2.24 (-5.62%) 16:08 Today Medallia sees Q1 revenue $126M-$128M, consensus $128.52M. 16:07 Today Medallia reports Q4 EPS (1c), consensus (1c) 12/03/20 Medallia sees Q4 revenue $123.5M-$125.5M, consensus $122.83M 12/03/20 Medallia reports Q3 EPS 1c, consensus (1c) MDLA Medallia $37.59 / -2.24 (-5.62%) 12/03/20 Fly Intel: After-Hours Movers 03/10/21 2nd Annual Enterprise Comms Virtual Summit 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Medallia - MDLA
Earnings	SmileDirectClub reports Q4 (9c) EPS , consensus (10c) » 16:09 03/04/21 03/04 16:09 03/04/21 16:09 SDC SmileDirectClub $10.61 / -0.3 (-2.75%) Reports Q4 revenue $185M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SDC SmileDirectClub $10.61 / -0.3 (-2.75%) 02/25/21 SmileDirectClub to bring telehealth solution to the Netherlands 02/24/21 SmileDirectClub partners with National Dental 02/23/21 SmileDirectClub launches new Pro Whitening System 02/17/21 SmileDirectClub announces Walgreens as retail partner SDC SmileDirectClub $10.61 / -0.3 (-2.75%) 12/08/20 Wolfe Research SmileDirectClub upgraded to Outperform from Peer Perform at Wolfe Research 11/24/20 JPMorgan JPMorgan reiterates Overweight on SmileDirectClub after management meetings 09/17/20 Stifel SmileDirectClub price target raised to $14 from $11 at Stifel 09/09/20 Wolfe Research Wolfe Research upgrades SmileDirectClub to Peer Perform as shifts pay off SDC SmileDirectClub $10.61 / -0.3 (-2.75%) 13:23 Today Notable companies reporting after market close 11/16/20 SmileDirectClub reports Q3 EPS (11c), consensus (14c) 11/16/20 Notable companies reporting after market close 24 Nov 19 Nov SDC SmileDirectClub $10.61 / -0.3 (-2.75%) 12/09/20 SmileDirectClub restarts legal dispute with Candid Care, Bloomberg reports SDC SmileDirectClub $10.61 / -0.3 (-2.75%) 10:40 Today Fly Intel: What to watch in SmileDirectClub's earnings report 12/08/20 Fly Intel: After-Hours Movers 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 16:30 Today SmileDirectClub - SDC SDC SmileDirectClub $10.61 / -0.3 (-2.75%) 12:45 Today SmileDirectClub call volume above normal and directionally bullish 01/28/21 SmileDirectClub call volume above normal and directionally bullish 01/26/21 Unusually active option classes on open January 26th 01/25/21 SmileDirectClub call volume above normal and directionally bullish
Hot Stocks	Slack Technologies reports Q4 calculated billings $359.9M, up 41% year-over-year » 16:09 03/04/21 03/04 16:09 03/04/21 16:09 WORK Slack Technologies $39.89 / -0.34 (-0.85%) Reports Q4 Calculated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WORK Slack Technologies $39.89 / -0.34 (-0.85%) 02/17/21 Slack Technologies, Salesforce receive second information request from DOJ 01/04/21 Slack says customers may have trouble loading messages, connecting 12/01/20 Salesforce acquires Slack in cash and stock deal worth $27.7B 12/01/20 Salesforce to acquire Slack in cash and stock deal worth $27.7B WORK Slack Technologies $39.89 / -0.34 (-0.85%) 12/09/20 Morgan Stanley Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley 12/09/20 Canaccord Salesforce valuation compelling especially on pullback, says Canaccord 12/09/20 Morgan Stanley Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley 12/03/20 Wedbush Slack Technologies upgraded to Neutral from Underperform at Wedbush WORK Slack Technologies $39.89 / -0.34 (-0.85%) 16:07 Today Slack Technologies reports Q4 EPS (1c), consensus (3c) 13:23 Today Notable companies reporting after market close 02/25/21 Slack Technologies reports preliminary Q4 revenue $250.6M, consensus $239.41M 12/01/20 Slack reports Q3 adjusted EPS 1c, consensus (4c) WORK Slack Technologies $39.89 / -0.34 (-0.85%) 12/05/20 Salesforce paying huge price for Slack, deal might not work, Barron's says 11/30/20 Salesforce deal for Slack coming tomorrow at premium, CNBC reports 11/30/20 Salesforce to acquire Slack at premium to current share price, CNBC reports 11/30/20 Salesforce acquisition of Slack to be announced tomorrow, CNBC reports WORK Slack Technologies $39.89 / -0.34 (-0.85%) 11:16 Today Fly Intel: What to watch in Slack earnings report 02/28/21 Opening Day: Coinbase files to go public 02/17/21 Fly Intel: Pre-market Movers 12/02/20 Fly Intel: Wall Street's top stories for Wednesday WORK Slack Technologies $39.89 / -0.34 (-0.85%) 02/11/21 Slack call volume above normal and directionally bullish 02/01/21 Slack put volume heavy and directionally bearish 01/20/21 Slack call volume above normal and directionally bullish 12/01/20 Notable open interest changes for December 1st

Earnings	Soliton reports Q4 EPS (22c), consensus (23c) » 16:09 03/04/21 03/04 16:09 03/04/21 16:09 SOLY Soliton $12.20 / -0.94 (-7.15%) Brad Hauser,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events SOLY Soliton $12.20 / -0.94 (-7.15%) 03/02/21 Soliton selects RESONIC as brand name for FDA-cleared RAP device 02/23/21 Soliton announces pre-clinical study in animals on liver fibrosis 02/01/21 Soliton announces FDA clearance of its RAP technology 01/26/21 Soliton announces collaboration with U.S. Navy for RAP device SOLY Soliton $12.20 / -0.94 (-7.15%) 02/08/21 Maxim Soliton price target raised to $25 from $22 at Maxim 02/02/21 Cantor Fitzgerald Soliton price target raised to $20 from $12 at Cantor Fitzgerald 07/15/20 Cantor Fitzgerald Soliton initiated with an Overweight at Cantor Fitzgerald 06/16/20 Roth Capital Soliton price target raised to $16 from $14 at Roth Capital SOLY Soliton $12.20 / -0.94 (-7.15%) 11/12/20 Soliton reports Q3 EPS (17c), consensus (17c) 26 Jun 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 16:30 Today Soliton - SOLY
Earnings	Veritone sees FY21 revenue $76M-$81M, consensus $68.3M » 16:09 03/04/21 03/04 16:09 03/04/21 16:09 VERI Veritone $34.86 / -1.55 (-4.26%) Sees FY21 adjusted net… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options VERI Veritone $34.86 / -1.55 (-4.26%) 02/09/21 Veritone continues international expansion through agreement with Peru's CRP Rad 01/19/21 Veritone, Base Media Cloud announce six-year agreement 01/11/21 Veritone announces strategic relationship with Alteryx 12/09/20 Veritone enters new content licensing agreement with Brave Bison VERI Veritone $34.86 / -1.55 (-4.26%) 02/23/21 Roth Capital Veritone price target raised to $42 from $31 at Roth Capital 12/21/20 Roth Capital Veritone price target raised to $31 from $20 at Roth Capital 12/21/20 Stifel Veritone initiated with a Hold at Stifel 11/19/20 Roth Capital Veritone price target raised to $20 from $18 at Roth Capital VERI Veritone $34.86 / -1.55 (-4.26%) 16:08 Today Veritone sees Q1 revenue $17M-$17.5M, consensus $15.41M 16:07 Today Veritone reports Q4 adjusted EPS (14c), consensus (15c) 11/09/20 Veritone sees Q4 revenue $16M-$16.4M, consensus $14.95M 11/09/20 Veritone reports Q3 EPS (15c), consensus (20c) 03 Dec VERI Veritone $34.86 / -1.55 (-4.26%) 12/02/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Veritone - VERI VERI Veritone $34.86 / -1.55 (-4.26%) 12/07/20 Largest borrow rate increases among liquid names
Hot Stocks	Fiesta Restaurant sees comparable restaurant sales positive in 2021 » 16:08 03/04/21 03/04 16:08 03/04/21 16:08 FRGI Fiesta Restaurant $15.61 / -0.86 (-5.22%) Fiesta Restaurant said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FRGI Fiesta Restaurant $15.61 / -0.86 (-5.22%) 01/11/21 Fiesta Restaurant Group reports Q4 Pollo Tropical SSS down 8.2% 10/05/20 Fiesta Restaurant says Q3 Pollo Tropical SSS fell 11.1%, Taco Cabana fell 14.2% FRGI Fiesta Restaurant $15.61 / -0.86 (-5.22%) 08/24/20 Piper Sandler Fiesta Restaurant price target raised to $10 from $8 at Piper Sandler 08/06/20 Raymond James Fiesta Restaurant upgraded to Outperform from Market Perform at Raymond James FRGI Fiesta Restaurant $15.61 / -0.86 (-5.22%) 16:07 Today Fiesta Restaurant reports Q4 adjusted EPS 7c, consensus 6c 16:30 Today Fiesta Restaurant - FRGI
Earnings	Medallia sees Q1 revenue $126M-$128M, consensus $128.52M. » 16:08 03/04/21 03/04 16:08 03/04/21 16:08 MDLA Medallia $37.51 / -2.32 (-5.82%) Sees Q1 subscription… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MDLA Medallia $37.51 / -2.32 (-5.82%) 03/01/21 Medallia announces partnership with USA Rugby 01/21/21 U.S. HHS selects Medallia to improve key services 01/19/21 Medallia Speech gets FedRAM authorization, HIPAA compliance 01/07/21 Medallia's video feedback solution LivingLens achieves HIPAA compliance MDLA Medallia $37.51 / -2.32 (-5.82%) 06:38 Today Citi Citi adds Medallia to 'Value Creators' list, removes Dropbox 02/23/21 Citi Medallia upgraded to Buy from Neutral at Citi 01/19/21 BTIG Medallia price target raised to $49 from $37 at BTIG 01/19/21 BofA Medallia initiated with a Buy at BofA MDLA Medallia $37.51 / -2.32 (-5.82%) 16:07 Today Medallia reports Q4 EPS (1c), consensus (1c) 12/03/20 Medallia sees Q4 revenue $123.5M-$125.5M, consensus $122.83M 12/03/20 Medallia reports Q3 EPS 1c, consensus (1c) 12/03/20 Notable companies reporting after market close MDLA Medallia $37.51 / -2.32 (-5.82%) 12/03/20 Fly Intel: After-Hours Movers 09/04/20 Fly Intel: Wall Street's top stories for Friday 03/10/21 2nd Annual Enterprise Comms Virtual Summit 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Medallia - MDLA
Earnings	Veritone sees Q1 revenue $17M-$17.5M, consensus $15.41M » 16:08 03/04/21 03/04 16:08 03/04/21 16:08 VERI Veritone $34.80 / -1.61 (-4.42%) Sees Q1 adjusted net… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options VERI Veritone $34.80 / -1.61 (-4.42%) 02/09/21 Veritone continues international expansion through agreement with Peru's CRP Rad 01/19/21 Veritone, Base Media Cloud announce six-year agreement 01/11/21 Veritone announces strategic relationship with Alteryx 12/09/20 Veritone enters new content licensing agreement with Brave Bison VERI Veritone $34.80 / -1.61 (-4.42%) 02/23/21 Roth Capital Veritone price target raised to $42 from $31 at Roth Capital 12/21/20 Roth Capital Veritone price target raised to $31 from $20 at Roth Capital 12/21/20 Stifel Veritone initiated with a Hold at Stifel 11/19/20 Roth Capital Veritone price target raised to $20 from $18 at Roth Capital VERI Veritone $34.80 / -1.61 (-4.42%) 16:07 Today Veritone reports Q4 adjusted EPS (14c), consensus (15c) 11/09/20 Veritone sees Q4 revenue $16M-$16.4M, consensus $14.95M 11/09/20 Veritone reports Q3 EPS (15c), consensus (20c) 03 Dec VERI Veritone $34.80 / -1.61 (-4.42%) 12/02/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Veritone - VERI VERI Veritone $34.80 / -1.61 (-4.42%) 12/07/20 Largest borrow rate increases among liquid names

Earnings	Turtle Beach reports Q4 adjusted EPS 984c, consensus 78c » 16:08 03/04/21 03/04 16:08 03/04/21 16:08 HEAR Turtle Beach $28.51 / -0.74 (-2.53%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HEAR Turtle Beach $28.51 / -0.74 (-2.53%) 01/13/21 Turtle Beach acquires Neat Microphones, terms not disclosed 11/19/20 Turtle Beach and TIdal music platform expand partnership 10/16/20 Video game hardware spending rose 15% year-over-year in September, says NPD HEAR Turtle Beach $28.51 / -0.74 (-2.53%) 02/12/21 Maxim Turtle Beach price target raised to $42 from $28 at Maxim 02/11/21 Stifel Turtle Beach price target raised to $38 from $23.50 at Stifel 02/11/21 DA Davidson Turtle Beach price target raised to $38 from $31 at DA Davidson 02/11/21 Lake Street Turtle Beach price target raised to $40 from $30 at Lake Street HEAR Turtle Beach $28.51 / -0.74 (-2.53%) 02/10/21 Turtle Beach sees Q4 adjusted EPS 73c-82c, consensus 47c 11/05/20 Turtle Beach raises FY20 adj. EPS view to $1.75 from 80c, consensus 96c 11/05/20 Turtle Beach reports Q3 EPS $1.04, consensus 23c HEAR Turtle Beach $28.51 / -0.74 (-2.53%) 09/29/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 17:00 Today Turtle Beach - HEAR
Earnings	Veritone reports Q4 adjusted EPS (14c), consensus (15c) » 16:07 03/04/21 03/04 16:07 03/04/21 16:07 VERI Veritone $34.80 / -1.61 (-4.42%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options VERI Veritone $34.80 / -1.61 (-4.42%) 02/09/21 Veritone continues international expansion through agreement with Peru's CRP Rad 01/19/21 Veritone, Base Media Cloud announce six-year agreement 01/11/21 Veritone announces strategic relationship with Alteryx 12/09/20 Veritone enters new content licensing agreement with Brave Bison VERI Veritone $34.80 / -1.61 (-4.42%) 02/23/21 Roth Capital Veritone price target raised to $42 from $31 at Roth Capital 12/21/20 Roth Capital Veritone price target raised to $31 from $20 at Roth Capital 12/21/20 Stifel Veritone initiated with a Hold at Stifel 11/19/20 Roth Capital Veritone price target raised to $20 from $18 at Roth Capital VERI Veritone $34.80 / -1.61 (-4.42%) 11/09/20 Veritone sees Q4 revenue $16M-$16.4M, consensus $14.95M 11/09/20 Veritone reports Q3 EPS (15c), consensus (20c) 03 Dec VERI Veritone $34.80 / -1.61 (-4.42%) 12/02/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Veritone - VERI VERI Veritone $34.80 / -1.61 (-4.42%) 12/07/20 Largest borrow rate increases among liquid names
Hot Stocks	Smith & Wesson Brands announces $100M share repurchase plan » 16:07 03/04/21 03/04 16:07 03/04/21 16:07 SWBI Smith & Wesson Brands $15.60 / -0.73 (-4.47%) Deana McPherson,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SWBI Smith & Wesson Brands $15.60 / -0.73 (-4.47%) 03/03/21 FBI reports 3.44M NICS firearm background checks in February 01/06/21 Firearms makers up amid Capitol protests, lockdown 01/04/21 FBI reports 3.94M NICS firearm background checks in December 12/16/20 Smith & Wesson Brands authorizes $50M stock repurchase plan SWBI Smith & Wesson Brands $15.60 / -0.73 (-4.47%) 08:49 Today B. Riley Securities B. Riley starts American Outdoor Brands with Buy, $32 price target 12/04/20 Lake Street Lake Street ups Smith & Wesson Brands price target to $28 after earnings 10/05/20 B. Riley Securities Firearm demand has seen meaningful uptick, says B. Riley Securities 09/24/20 Fly Intel: Top five analyst initiations SWBI Smith & Wesson Brands $15.60 / -0.73 (-4.47%) 16:06 Today Smith & Wesson Brands reports Q3 EPS $1.12, consensus 76c 12/03/20 Smith & Wesson Brands reports Q2 adjusted EPS 93c, consensus 63c SWBI Smith & Wesson Brands $15.60 / -0.73 (-4.47%) 12/15/20 Smith & Wesson sues New Jersey to block subpoena related to marketing, WSJ says SWBI Smith & Wesson Brands $15.60 / -0.73 (-4.47%) 12/16/20 Fly Intel: After-Hours Movers 12/03/20 Fly Intel: After-Hours Movers 17:00 Today Smith & Wesson Brands - SWBI SWBI Smith & Wesson Brands $15.60 / -0.73 (-4.47%) 02/18/21 Smith and Wesson call volume above normal and directionally bullish 02/03/21 Smith and Wesson put volume heavy and directionally bearish 01/27/21 Smith and Wesson put volume heavy and directionally bearish 01/11/21 Smith and Wesson call volume above normal and directionally bullish
Earnings	Fiesta Restaurant reports Q4 adjusted EPS 7c, consensus 6c » 16:07 03/04/21 03/04 16:07 03/04/21 16:07 FRGI Fiesta Restaurant $15.61 / -0.86 (-5.22%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events FRGI Fiesta Restaurant $15.61 / -0.86 (-5.22%) 01/11/21 Fiesta Restaurant Group reports Q4 Pollo Tropical SSS down 8.2% 10/05/20 Fiesta Restaurant says Q3 Pollo Tropical SSS fell 11.1%, Taco Cabana fell 14.2% FRGI Fiesta Restaurant $15.61 / -0.86 (-5.22%) 08/24/20 Piper Sandler Fiesta Restaurant price target raised to $10 from $8 at Piper Sandler 08/06/20 Raymond James Fiesta Restaurant upgraded to Outperform from Market Perform at Raymond James 16:30 Today Fiesta Restaurant - FRGI
Earnings	Slack Technologies reports Q4 EPS (1c), consensus (3c) » 16:07 03/04/21 03/04 16:07 03/04/21 16:07 WORK Slack Technologies $39.91 / -0.32 (-0.80%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WORK Slack Technologies $39.91 / -0.32 (-0.80%) 02/17/21 Slack Technologies, Salesforce receive second information request from DOJ 01/04/21 Slack says customers may have trouble loading messages, connecting 12/01/20 Salesforce acquires Slack in cash and stock deal worth $27.7B 12/01/20 Salesforce to acquire Slack in cash and stock deal worth $27.7B WORK Slack Technologies $39.91 / -0.32 (-0.80%) 12/09/20 Morgan Stanley Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley 12/09/20 Canaccord Salesforce valuation compelling especially on pullback, says Canaccord 12/09/20 Morgan Stanley Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley 12/03/20 Wedbush Slack Technologies upgraded to Neutral from Underperform at Wedbush WORK Slack Technologies $39.91 / -0.32 (-0.80%) 13:23 Today Notable companies reporting after market close 02/25/21 Slack Technologies reports preliminary Q4 revenue $250.6M, consensus $239.41M 12/01/20 Slack reports Q3 adjusted EPS 1c, consensus (4c) 09/08/20 Slack Technologies sees FY21 EPS (14c) to (13c), consensus (16c) WORK Slack Technologies $39.91 / -0.32 (-0.80%) 12/05/20 Salesforce paying huge price for Slack, deal might not work, Barron's says 11/30/20 Salesforce deal for Slack coming tomorrow at premium, CNBC reports 11/30/20 Salesforce to acquire Slack at premium to current share price, CNBC reports 11/30/20 Salesforce acquisition of Slack to be announced tomorrow, CNBC reports WORK Slack Technologies $39.91 / -0.32 (-0.80%) 11:16 Today Fly Intel: What to watch in Slack earnings report 02/28/21 Opening Day: Coinbase files to go public 02/17/21 Fly Intel: Pre-market Movers 12/02/20 Fly Intel: Wall Street's top stories for Wednesday WORK Slack Technologies $39.91 / -0.32 (-0.80%) 02/11/21 Slack call volume above normal and directionally bullish 02/01/21 Slack put volume heavy and directionally bearish 01/20/21 Slack call volume above normal and directionally bullish 12/01/20 Notable open interest changes for December 1st

Earnings	Medallia reports Q4 EPS (1c), consensus (1c) » 16:07 03/04/21 03/04 16:07 03/04/21 16:07 MDLA Medallia $37.58 / -2.25 (-5.65%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MDLA Medallia $37.58 / -2.25 (-5.65%) 03/01/21 Medallia announces partnership with USA Rugby 01/21/21 U.S. HHS selects Medallia to improve key services 01/19/21 Medallia Speech gets FedRAM authorization, HIPAA compliance 01/07/21 Medallia's video feedback solution LivingLens achieves HIPAA compliance MDLA Medallia $37.58 / -2.25 (-5.65%) 06:38 Today Citi Citi adds Medallia to 'Value Creators' list, removes Dropbox 02/23/21 Citi Medallia upgraded to Buy from Neutral at Citi 01/19/21 BTIG Medallia price target raised to $49 from $37 at BTIG 01/19/21 BofA Medallia initiated with a Buy at BofA MDLA Medallia $37.58 / -2.25 (-5.65%) 12/03/20 Medallia sees Q4 revenue $123.5M-$125.5M, consensus $122.83M 12/03/20 Medallia reports Q3 EPS 1c, consensus (1c) 12/03/20 Notable companies reporting after market close MDLA Medallia $37.58 / -2.25 (-5.65%) 12/03/20 Fly Intel: After-Hours Movers 09/04/20 Fly Intel: Wall Street's top stories for Friday 03/10/21 2nd Annual Enterprise Comms Virtual Summit 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Medallia - MDLA
Hot Stocks	DZS acquires RIFT, terms undisclosed » 16:06 03/04/21 03/04 16:06 03/04/21 16:06 DZSI DZS $15.88 / -1.63 (-9.31%) DZS announced that it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Options DZSI DZS $15.88 / -1.63 (-9.31%) 02/18/21 DZS partners with NCTC to bring fiber access to rural operators 02/08/21 DZS completes acquisition of Optelian 01/20/21 DZS acquires Optelian, terms not disclosed 01/04/21 DZS appoints Matt Bross, Barbara Carbone to board of directors DZSI DZS $15.88 / -1.63 (-9.31%) 03/01/21 Needham DZS initiated with a Buy at Needham 03/01/21 Needham DZS initiated with a Buy at Needham 02/23/21 Northland DZS price target raised to $22 from $17 at Northland 02/23/21 B. Riley Securities DZS price target raised to $23.50 from $21 at B. Riley Securities DZSI DZS $15.88 / -1.63 (-9.31%) 02/22/21 DZS sees FY21 revenue $310M-$330M, consensus $321.2M 02/22/21 DZS sees Q1 revenue $70M-$75M, consensus $70.22M 02/22/21 DZS reports Q4 adjusted EPS (6c), consensus 5c 10/29/20 DZS sees Q4 revenue $75M-$80M, consensus $85.61M 27 Jan DZSI DZS $15.88 / -1.63 (-9.31%) 01/06/21 Fifteen new option listings on January 6th
Earnings	Smith & Wesson Brands reports Q3 EPS $1.12, consensus 76c » 16:06 03/04/21 03/04 16:06 03/04/21 16:06 SWBI Smith & Wesson Brands $15.63 / -0.7 (-4.29%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SWBI Smith & Wesson Brands $15.63 / -0.7 (-4.29%) 03/03/21 FBI reports 3.44M NICS firearm background checks in February 01/06/21 Firearms makers up amid Capitol protests, lockdown 01/04/21 FBI reports 3.94M NICS firearm background checks in December 12/16/20 Smith & Wesson Brands authorizes $50M stock repurchase plan SWBI Smith & Wesson Brands $15.63 / -0.7 (-4.29%) 08:49 Today B. Riley Securities B. Riley starts American Outdoor Brands with Buy, $32 price target 12/04/20 Lake Street Lake Street ups Smith & Wesson Brands price target to $28 after earnings 10/05/20 B. Riley Securities Firearm demand has seen meaningful uptick, says B. Riley Securities 09/24/20 Fly Intel: Top five analyst initiations SWBI Smith & Wesson Brands $15.63 / -0.7 (-4.29%) 12/03/20 Smith & Wesson Brands reports Q2 adjusted EPS 93c, consensus 63c SWBI Smith & Wesson Brands $15.63 / -0.7 (-4.29%) 12/15/20 Smith & Wesson sues New Jersey to block subpoena related to marketing, WSJ says SWBI Smith & Wesson Brands $15.63 / -0.7 (-4.29%) 12/16/20 Fly Intel: After-Hours Movers 12/03/20 Fly Intel: After-Hours Movers 17:00 Today Smith & Wesson Brands - SWBI SWBI Smith & Wesson Brands $15.63 / -0.7 (-4.29%) 02/18/21 Smith and Wesson call volume above normal and directionally bullish 02/03/21 Smith and Wesson put volume heavy and directionally bearish 01/27/21 Smith and Wesson put volume heavy and directionally bearish 01/11/21 Smith and Wesson call volume above normal and directionally bullish
Earnings	Senseonics sees FY21 revenue $12M-$15M, consensus $13.15M 16:06 03/04/21 03/04 16:06 03/04/21 16:06 SENS Senseonics $2.70 / -0.47 (-14.83%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options SENS Senseonics $2.70 / -0.47 (-14.83%) 02/01/21 Ascensia commences sales, marketing activities for Eversense XL CGM 01/21/21 Senseonics Holder Masters reports 5.89% active stake 01/19/21 Senseonics announces positive coverage decision for Eversense CGM 10/05/20 Senseonics submits PMA application for 180-Day Eversense System to the FDA SENS Senseonics $2.70 / -0.47 (-14.83%) 01/20/21 BTIG BTIG cuts Senseonics to Neutral, sees no fundamental reason for rapid rise 01/20/21 BTIG Senseonics downgraded to Neutral from Buy at BTIG 01/20/21 Craig-Hallum Senseonics downgraded to Sell at Craig-Hallum 01/20/21 Craig-Hallum Senseonics downgraded to Sell from Hold at Craig-Hallum SENS Senseonics $2.70 / -0.47 (-14.83%) 16:06 Today Senseonics reports Q4 EPS (41c), consensus (9c) 12/23/20 Senseonics sees FY21 revenue $12M-$15M, consensus $12.7M 12/23/20 Senseonics sees Q4 revenue $3.5M, consensus $2.49M 11/09/20 Senseonics reports Q3 EPS (10c), consensus (6c) 22 Jan SENS Senseonics $2.70 / -0.47 (-14.83%) 01/22/21 Fly Intel: Pre-market Movers 12/24/20 Fly Intel: Pre-market Movers 16:30 Today Senseonics - SENS SENS Senseonics $2.70 / -0.47 (-14.83%) 15:04 Today Senseonics options imply 28.4% move in share price post-earnings 02/08/21 Unusually active option classes on open February 8th 01/06/21 Largest borrow rate increases among liquid names 12/24/20 Unusually active option classes on open December 24th
Earnings	Senseonics reports Q4 EPS (41c), consensus (9c) » 16:06 03/04/21 03/04 16:06 03/04/21 16:06 SENS Senseonics $2.70 / -0.47 (-14.83%) Reports Q4 revenue $3.9M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options SENS Senseonics $2.70 / -0.47 (-14.83%) 02/01/21 Ascensia commences sales, marketing activities for Eversense XL CGM 01/21/21 Senseonics Holder Masters reports 5.89% active stake 01/19/21 Senseonics announces positive coverage decision for Eversense CGM 10/05/20 Senseonics submits PMA application for 180-Day Eversense System to the FDA SENS Senseonics $2.70 / -0.47 (-14.83%) 01/20/21 BTIG BTIG cuts Senseonics to Neutral, sees no fundamental reason for rapid rise 01/20/21 BTIG Senseonics downgraded to Neutral from Buy at BTIG 01/20/21 Craig-Hallum Senseonics downgraded to Sell at Craig-Hallum 01/20/21 Craig-Hallum Senseonics downgraded to Sell from Hold at Craig-Hallum SENS Senseonics $2.70 / -0.47 (-14.83%) 12/23/20 Senseonics sees FY21 revenue $12M-$15M, consensus $12.7M 12/23/20 Senseonics sees Q4 revenue $3.5M, consensus $2.49M 11/09/20 Senseonics reports Q3 EPS (10c), consensus (6c) 22 Jan SENS Senseonics $2.70 / -0.47 (-14.83%) 01/22/21 Fly Intel: Pre-market Movers 12/24/20 Fly Intel: Pre-market Movers 16:30 Today Senseonics - SENS SENS Senseonics $2.70 / -0.47 (-14.83%) 15:04 Today Senseonics options imply 28.4% move in share price post-earnings 02/08/21 Unusually active option classes on open February 8th 01/06/21 Largest borrow rate increases among liquid names 12/24/20 Unusually active option classes on open December 24th

Earnings	Acorda Therapeutics reports Q4 EPS ($2.50), one estimate ($1.48) » 16:05 03/04/21 03/04 16:05 03/04/21 16:05 ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 02/19/21 Acorda Therapeutics chief, business operations officer to depart 01/13/21 Catalent to acquire manufacturing operations from Acorda Therapeutics 01/13/21 Acorda Therapeutics sees Q4 Inbrija net revenue of $9M, Ampyra sales of $25M 01/13/21 Acorda Therapeutics announces corporate restructuring ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 01/13/21 Cowen Acorda Therapeutics price target raised to $35 from $5 at Cowen ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 11/03/20 Acorda Therapeutics backs FY20 AMPYRA net revenue, operating expense views 11/03/20 Acorda Therapeutics reports Q3 EPS (23c), consensus (30c) ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 10/19/20 Fly Intel: After-Hours Movers 16:30 Today Acorda Therapeutics - ACOR ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 02/12/21 Acorda Therapeutics options imply 17.4% move in share price post-earnings 11/16/20 Largest borrow rate increases among liquid names 11/09/20 Largest borrow rate increases among liquid names 11/03/20 Acorda Therapeutics options imply 28.1% move in share price post-earnings
Earnings	Silvercrest Asset reports Q4 adjusted EPS 31c, consensus 36c » 16:05 03/04/21 03/04 16:05 03/04/21 16:05 SAMG Silvercrest Asset $14.94 / +0.22 (+1.49%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events SAMG Silvercrest Asset $14.94 / +0.22 (+1.49%) 12/21/20 Janney Montgomery Scott Silvercrest Asset initiated with a Buy at Janney Montgomery Scott SAMG Silvercrest Asset $14.94 / +0.22 (+1.49%) 11/05/20 Silvercrest Asset reports Q3 adjusted EPS 35c, consensus 32c 03/05/21 Silvercrest Asset - SAMG
Recommendations	Kura Sushi price target raised to $42 from $28 at Stephens » 16:04 03/04/21 03/04 16:04 03/04/21 16:04 KRUS Kura Sushi $32.01 / -2.17 (-6.35%) Stephens analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings KRUS Kura Sushi $32.01 / -2.17 (-6.35%) 03/03/21 BTIG Kura Sushi price target raised to $40 from $22 at BTIG 01/12/21 Craig-Hallum Kura Sushi upgraded to Buy from Hold at Craig-Hallum 11/16/20 Craig-Hallum Kura Sushi price target raised to $17 from $11 at Craig-Hallum 10/06/20 Daiwa Kura Sushi initiated with an Outperform at Daiwa KRUS Kura Sushi $32.01 / -2.17 (-6.35%) 01/11/21 Kura Sushi reports Q1 adjusted EPS (71c), consensus (65c) 11/16/20 Kura Sushi reports Q4 EPS (82c), consensus (58c)
Hot Stocks	Ocular Therapeutix gets FDA acceptance of NDA for Dextenza » 16:04 03/04/21 03/04 16:04 03/04/21 16:04 OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) Ocular Therapeutix… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 03/01/21 Ocular Therapeutics says 1st patient dosed in phase 2 clinical trial of OTX-DED 01/20/21 Ocular Therapeutix to present new OTX-TIC data at Glaucoma 360 Forum 12/22/20 Ocular Therapeutix submits Dextenza sNDA to FDA 11/04/20 Ocular Therapeutix receives permanent category I CPT code from AMA OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 02/12/21 Piper Sandler Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler 12/30/20 JMP Securities Ocular Therapeutix price target raised to $30 from $20 at JMP Securities 12/28/20 Fly Intel: Top five analyst calls 12/28/20 H.C. Wainwright Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 11/05/20 Ocular Therapeutix reports Q3 EPS (21c), consensus (24c) 10/07/20 Ocular Therapeutix reports preliminary Q3 revenue $5.8M-$5.9M, consensus $3.91M 16 Dec 14 Oct 20 May OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 12/28/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers 03/11/21 Ocular Therapeutix - OCUL
Hot Stocks	CoStar withdraws bid to acquire CoreLogic, ends further acquisition talks » 16:04 03/04/21 03/04 16:04 03/04/21 16:04 CSGP CoStar Group $755.60 / -7.475 (-0.98%) , CLGX CoreLogic $82.23 / -0.58 (-0.70%) CoStar Group (CSGP)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 14:49 Today CoStar to pay RentPath $52M in settlement of break-up fee litigation 06:40 Today CoreLogic board concludes CoStar's updated proposal is not superior 03/01/21 CoreLogic confirms receipt of revised proposal from CoStar 03/01/21 CoStar Group submits revised proposal to acquire CoreLogic for $90.00 per share CLGX CoreLogic $82.23 / -0.58 (-0.70%) 06:40 Today CoreLogic board concludes CoStar's updated proposal is not superior 03/01/21 CoreLogic confirms receipt of revised proposal from CoStar 03/01/21 CoStar Group submits revised proposal to acquire CoreLogic for $90.00 per share 02/18/21 Pentwater takes stake in CoreLogic, nominates its CEO to board CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/04/21 Stephens CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens 12/22/20 JMP Securities RealPage price target raised to $101 from $80 at JMP Securities 11/23/20 Wells Fargo CoStar Group price target raised to $990 from $915 at Wells Fargo 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist CLGX CoreLogic $82.23 / -0.58 (-0.70%) 02/04/21 Stephens CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens 01/06/21 Wolfe Research CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/23/21 CoStar Group sees FY21 EPS $10.83-$11.03, consensus $11.42 02/23/21 CoStar Group sees Q1 EPS $2.33-$2.43, consensus $2.64 02/23/21 CoStar Group reports Q4 EPS $2.85, consensus $2.41 10/27/20 CoStar Group sees FY20 EPS $9.39-$9.49, consensus $9.36 CLGX CoreLogic $82.23 / -0.58 (-0.70%) 03/01/21 CoreLogic reports Q4 adjusted EPS $1.51, consensus $1.17 12/11/20 CoreLogic raises FY21 adjusted EPS view to $4.40-$4.65 from $4.00-$4.20 12/11/20 CoreLogic raises FY20 adjusted EPS view to $4.15-$4.25 from $3.65 10/22/20 CoreLogic sees FY20 results at upper end of guidance range 21 May CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/25/21 CoreLogic asks CoStar for more assurances on antitrust risk, Reuters reports 02/04/21 CoStar studying CoreLogic options, including possible new bid, WSJ says 02/04/21 CoStar considering new bid for CoreLogic, WSJ says 02/04/21 CoreLogic sold to private equity for $80 per share, CNBC's Faber reports CLGX CoreLogic $82.23 / -0.58 (-0.70%) 02/25/21 CoreLogic asks CoStar for more assurances on antitrust risk, Reuters reports 02/04/21 CoStar studying CoreLogic options, including possible new bid, WSJ says 02/04/21 CoStar considering new bid for CoreLogic, WSJ says 02/04/21 CoreLogic sold to private equity for $80 per share, CNBC's Faber reports CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/23/21 Fly Intel: After-Hours Movers 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/16/21 Fly Intel: Pre-market Movers CLGX CoreLogic $82.23 / -0.58 (-0.70%) 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/16/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday

Events

Earnings calls, analyst events, roadshows and more

Today at 16:30

Fed Balance Sheet Reserve Bank Credit W/W: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Level: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Total Assets W/W: Week 3/3/21 Government Event
CLPT
Today at 16:30

ClearPoint Neuro - CLPT Conference Calls
SIGA
Today at 16:30

Siga Technologies - SIGA Conference Calls
FLGT
Today at 16:30

Fulgent Genetics - FLGT Conference Calls
SYN
Today at 16:30

Synthetic Biologics - SYN Conference Calls
CLXT
Today at 16:30

Calyxt - CLXT Conference Calls
VRAY
Today at 16:30

ViewRay - VRAY Conference Calls
SOLY
Today at 16:30

Soliton - SOLY Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital $149.49 7M Shares
Fri	No deals

View All Syndicate Announcements »

Intersect ENT announces CMS approval of SINUVA for reimbursement

TODAY'S FREE FLY STORIES

Get Full Fly Access